Oncology News and Research

RSS
Eli Lilly to publish grant and contribution information

Eli Lilly to publish grant and contribution information

Cancer Research Technology licenses therapeutic antibodies to Peptech

Cancer Research Technology licenses therapeutic antibodies to Peptech

Tarceva extends life of patients with pancreatic cancer

Tarceva extends life of patients with pancreatic cancer

Potential new treatment for desmoid fibromatosis

Potential new treatment for desmoid fibromatosis

New mechanism identified for resistance to targeted lung cancer drugs

New mechanism identified for resistance to targeted lung cancer drugs

Genetic differences may explain why many Asian women who never smoked develop lung cancer

Genetic differences may explain why many Asian women who never smoked develop lung cancer

Mode of action of EpiCept-licensed cancer compound profiled at AACR

Mode of action of EpiCept-licensed cancer compound profiled at AACR

Pharmacyclics announces NDA for Xcytrin injection

Pharmacyclics announces NDA for Xcytrin injection

NYU Medical Center partners with Rosetta Genomics to tackle mesothelioma

NYU Medical Center partners with Rosetta Genomics to tackle mesothelioma

New methods for treating lung cancer cells that have become resistant to new anti-cancer agents

New methods for treating lung cancer cells that have become resistant to new anti-cancer agents

Translocation kidney cancer after chemotherapy in childhood

Translocation kidney cancer after chemotherapy in childhood

ZARS announces Swedish marketing approval for Rapydan

ZARS announces Swedish marketing approval for Rapydan

Childhood sarcoma increases risk of blood clots

Childhood sarcoma increases risk of blood clots

Steven Piantadosi named as first Director of Samuel Oschin Comprehensive Cancer Institute

Steven Piantadosi named as first Director of Samuel Oschin Comprehensive Cancer Institute

New method predicts hip joint decay from chemotherapy

New method predicts hip joint decay from chemotherapy

Access Pharmaceuticals and Somanta Pharmaceuticals sign merger agreement

Access Pharmaceuticals and Somanta Pharmaceuticals sign merger agreement

Novel method to expand the number of immune system "natural killer" cells from blood cells outside the body

Novel method to expand the number of immune system "natural killer" cells from blood cells outside the body

Nanoparticle delivery system delivers cancer-suppressing gene in M. D. Anderson trial

Nanoparticle delivery system delivers cancer-suppressing gene in M. D. Anderson trial

More effective therapies for individual cancers  - personalized medicine

More effective therapies for individual cancers - personalized medicine

Scientists tackle cancer with different approaches

Scientists tackle cancer with different approaches

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.